An industry perspective on clinical development and regulatory strategies for subcutaneously administered high-dose biologics
Gerard Bruin, Ryan P. Nolan, Shelley Amendola, Dany Doucet, Sy Gebrekidan, Tanja Novkovic, Marie Picci, Ashlesha Raut, Christopher J. Rini, Peter Skutnik, Tania Thomas, Mitch Zhao, Beate Bittner
Topics & Concepts
Perspective (graphical)PharmacologyMedicineBusinessMedical physicsComputer scienceArtificial intelligenceBiosimilars and Bioanalytical MethodsBiomedical Ethics and RegulationBiomedical and Engineering Education